Terms: = Lung cancer AND NTRK1, ENSG00000198400, 4914, P04629, TRK1, MTC, DKFZp781I14186, p140-TrkA, TRKA, TRK AND Staging
13 results:
1. Head-to-Head Comparison of [
Ballal S; Yadav MP; Roesch F; Raju S; Satapathy S; Sheokand P; Moon ES; Martin M; Awarwal S; Tripathi M; Bal C
Thyroid; 2023 Aug; 33(8):974-982. PubMed ID: 37171126
[No Abstract] [Full Text] [Related]
2. [Imaging of medullary thyroid carcinoma].
Uhrig M; Delorme S
Radiologe; 2019 Nov; 59(11):992-1001. PubMed ID: 31367891
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of 68Ga PET/CT to Other Imaging Studies in Medullary Thyroid cancer: Superiority in Detecting Bone Metastases.
Castroneves LA; Coura Filho G; de Freitas RMC; Salles R; Moyses RA; Lopez RVM; Pereira MAA; Tavares MR; Jorge AAL; Buchpiguel CA; Hoff AO
J Clin Endocrinol Metab; 2018 Sep; 103(9):3250-3259. PubMed ID: 29846642
[TBL] [Abstract] [Full Text] [Related]
4. Medullary Thyroid Carcinoma: Imaging.
Delorme S; Raue F
Recent Results Cancer Res; 2015; 204():91-116. PubMed ID: 26494385
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic impact of N staging in 715 medullary thyroid cancer patients: proposal for a revised staging system.
Machens A; Dralle H
Ann Surg; 2013 Feb; 257(2):323-9. PubMed ID: 22968075
[TBL] [Abstract] [Full Text] [Related]
6. Three-gene expression signature predicts survival in early-stage squamous cell carcinoma of the lung.
Skrzypski M; Jassem E; Taron M; Sanchez JJ; Mendez P; Rzyman W; Gulida G; Raz D; Jablons D; Provencio M; Massuti B; Chaib I; Perez-Roca L; Jassem J; Rosell R
Clin Cancer Res; 2008 Aug; 14(15):4794-9. PubMed ID: 18676750
[TBL] [Abstract] [Full Text] [Related]
7. Sensitivity and prognostic value of positron emission tomography with F-18-fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary thyroid carcinoma treated with anticarcinoembryonic antigen-targeted radioimmunotherapy.
Oudoux A; Salaun PY; Bournaud C; Campion L; Ansquer C; Rousseau C; Bardet S; Borson-Chazot F; Vuillez JP; Murat A; Mirallié E; Barbet J; Goldenberg DM; Chatal JF; Kraeber-Bodéré F
J Clin Endocrinol Metab; 2007 Dec; 92(12):4590-7. PubMed ID: 17878252
[TBL] [Abstract] [Full Text] [Related]
8. Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients.
Szavcsur P; Godény M; Bajzik G; Lengyel E; Repa I; Trón L; Boér A; Vincze B; Póti Z; Szabolcs I; Esik O
Eur J Surg Oncol; 2005 Mar; 31(2):183-90. PubMed ID: 15698736
[TBL] [Abstract] [Full Text] [Related]
9. MEN 1 and 2: the role of diagnostic imaging.
Gollini P; Cataldi A; Fava C
Radiol Med; 2004; 107(1-2):78-87. PubMed ID: 15031699
[TBL] [Abstract] [Full Text] [Related]
10. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
Béhé M; Behr TM
Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
[TBL] [Abstract] [Full Text] [Related]
11. Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies.
Behr TM; Béhé MP
Semin Nucl Med; 2002 Apr; 32(2):97-109. PubMed ID: 11965605
[TBL] [Abstract] [Full Text] [Related]
12. Imaging tumors with peptide-based radioligands.
Behr TM; Gotthardt M; Barth A; Béhé M
Q J Nucl Med; 2001 Jun; 45(2):189-200. PubMed ID: 11476170
[TBL] [Abstract] [Full Text] [Related]
13. Diagnostic applications of radiolabeled peptides in nuclear endocrinology.
Behr TM; Béhé M; Becker W
Q J Nucl Med; 1999 Sep; 43(3):268-80. PubMed ID: 10568142
[TBL] [Abstract] [Full Text] [Related]